DCF — UH GENEVA MEDICAL CENTER
Enterprise Value: $58.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$58.7M
Enterprise Value
$15.7M
PV of Cash Flows
$43.0M
PV of Terminal Value
$69.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $63.4M | $7.3M | 12.0% | $3.2M | $2.9M |
| Year 2 | $65.3M | $8.2M | 13.0% | $3.8M | $3.1M |
| Year 3 | $67.3M | $9.1M | 14.0% | $4.4M | $3.3M |
| Year 4 | $69.3M | $9.7M | 14.0% | $4.8M | $3.3M |
| Year 5 | $71.4M | $10.2M | 14.0% | $5.1M | $3.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $58.7M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$61.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.11021207255518681
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5